Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 11651 [2013-03610]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as outlined
in (a) above will also appear with the agenda
for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in
(a) above will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an individual
in making a statement reveals personal
information (e.g., medical information) about
themselves that information will not usually
be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will,
however, review such revelations in
accordance with the FOIA and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such information. (4)
All disclosures of information concerning
third parties will be redacted. (5) If it comes
to the attention of the DFO that an individual
wishes to share information with the Board
but objects to doing so in a public forum, the
DFO will work with that individual, in
accordance with the Federal Advisory
Committee Act, to find a way that the Board
can hear such comments.
Contact Person for More Information:
Theodore Katz, DFO, NIOSH, CDC, 1600
Clifton Road, MS E–20, Atlanta, GA 30333,
telephone: (513) 533–6800, toll free: 1–800–
CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters To Be Discussed: The purpose of
the meeting is to discuss the potential for
forming an infectious disease laboratory
working group under the BSC, OID.
The agenda and any supplemental material
will be available at www.cdc.gov/oid/
BSC.html after March 1.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–03612 Filed 2–15–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
TKELLEY on DSK3SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 3:00–4:00 p.m. Eastern
Time, March 14, 2013.
Place: Teleconference.
Status: The meeting is open to the public;
the toll free dial in number is 1–877–951–
7311 with a passcode of 6420598.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
17:49 Feb 15, 2013
Jkt 229001
[FR Doc. 2013–03610 Filed 2–15–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
research, experiments, and demonstrations
relating to occupational safety and health and
to mine health. The Board of Scientific
Counselors shall provide guidance to the
Director, National Institute for Occupational
Safety and Health on research and prevention
programs. Specifically, the Board shall
provide guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and disseminating
results. The Board shall evaluate the degree
to which the activities of the National
Institute for Occupational Safety and Health:
(1) Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters To Be Discussed: NIOSH Director
Update; Implementation of the National
Academies Program Recommendations for
Construction Safety and Health, Respiratory
Disease Studies, and Traumatic Injury
Prevention, Nanotechnology Research
Strategic Plan, Influenza Research,
Agriculture, Forestry, and Fishing Sector
Update.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Roger Rosa, Ph.D., Designated Federal
Officer, BSC, NIOSH, CDC, 395 E Street SW.,
Suite 9200, Patriots Plaza Building,
Washington, DC 20201, telephone (202) 245–
0655, fax (202) 245–0664.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
BILLING CODE 4163–18–P
VerDate Mar<15>2010
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
11651
[FR Doc. 2013–03737 Filed 2–15–13; 8:45 am]
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Time and Dates: 8:30 a.m.–3:15 p.m.,
March 21, 2013.
Place: Patriots Plaza I, 395 E Street SW.,
Room 9200, Washington, DC 20201.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people. If
you wish to attend in person, please contact
NIOSH at (202) 245–0625 or (202) 245–0626
for information on building access.
Teleconference is available toll-free; please
dial (877) 328–2816, Participant Pass Code
6558291.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation the
Director, Centers for Disease Control and
Prevention, are authorized under Sections
301 and 308 of the Public Health Service Act
to conduct directly or by grants or contracts,
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Manufactured
Food Regulatory Program Standards
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
BILLING CODE 4163–19–P
Food and Drug Administration
[Docket No. FDA–2013–N–0115]
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
SUMMARY:
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Page 11651]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03610]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 3:00-4:00 p.m. Eastern Time, March 14, 2013.
Place: Teleconference.
Status: The meeting is open to the public; the toll free dial in
number is 1-877-951-7311 with a passcode of 6420598.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases, and the National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and priorities for programs;
research within the national centers; and overall strategic
direction and focus of OID and the national centers.
Matters To Be Discussed: The purpose of the meeting is to
discuss the potential for forming an infectious disease laboratory
working group under the BSC, OID.
The agenda and any supplemental material will be available at
www.cdc.gov/oid/BSC.html after March 1.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2013-03610 Filed 2-15-13; 8:45 am]
BILLING CODE 4163-18-P
